NCT02574676
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- Online registry South San Francisco, California, United States
Clinical trial condition
AL Amyloidosis
Explore clinical trials studying AL Amyloidosis. Study availability and eligibility vary by location and protocol.
54 public trials
21 recruiting studies
AL Amyloidosis trial results
NCT02632786
- Conditions
- AL Amyloidosis, Alzheimer Disease, Amyloidosis, +22 more
- Locations
-
- City of Hope Duarte, California, United States
- Stanford Cancer Institute (SCI) Stanford, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Mayo Clinic Jacksonville, Florida, United States
NCT01277016
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- Amyloidosis Research and Treatment Center Pavia, Italy
NCT02257905
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- CHRU Limoges Limoges, France
- University Hospital Eppendorf Hamburg, Germany
- University of Heidelberg Heidelberg, Germany
- University Hospital Basel, Switzerland
NCT01815086
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- University of Tennessee Medical Center Knoxville, Tennessee, United States
Completed
Radioimmunoimaging of AL Amyloidosis
NCT01409148
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- University of Tennessee Medical Center Knoxville, Tennessee, United States
Active, Not Recruiting
A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis
NCT06649695
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- South Australia Health Adelaide, Australia
- Westmead Hospital Sydney, Australia
- CHU Limoges Limoges, France
- University Hospital Essen Essen, Germany
Active, Not Recruiting
Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis
NCT04754945
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- University of California Orange, California, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Emory University Hospital Midtown Atlanta, Georgia, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
Active, Not Recruiting
Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
NCT05451771
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- Boston Medical Center Boston, Massachusetts, United States
- Mayo Clinic Rochester Rochester, Minnesota, United States
- Washington University School of Medicine St Louis, Missouri, United States
- New York Presbyterian Hospital/Columbia University Irving Medical Center New York, United States
Active, Not Recruiting
A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)
NCT04504825
- Conditions
- AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +13 more
- Locations
-
- Research Site Duarte, California, United States
- Research Site Palo Alto, California, United States
- Research Site San Francisco, California, United States
- Research Site Weston, Florida, United States